Indonesian Journal of Cancer
Vol 17, No 1 (2023): March

A Preliminary Study on Cancer Patients’ Quality of Life during the COVID-19 Pandemic

Ririn Afrian Sulistyawati (Department of Nursing Universitas Kusuma Husada Surakarta)
Santoso Santoso (Tugurejo Hospital, Semarang)
Lalu Muhammad Panji Azali (Department of Nursing Universitas Kusuma Husada Surakarta)
Galih Setia Adi (Department of Nursing Universitas Kusuma Husada Surakarta)



Article Info

Publish Date
28 Mar 2023

Abstract

Background: Cancer patients are 3.5 times more susceptible to COVID-19 than patients without cancer. The increasing number of COVID-19 patients is likely to impact cancer patients’ quality of life (QoL) significantly. This study aims to analyze the QoL of cancer patients during the COVID-19 pandemic. Methods: The method used is quantitative with a cross-sectional research design. In this study, 60 respondents were selected using the Consecutive Sampling Technique. The patient’s QoL was measured once by utilizing The World Health Organization Quality of Life Brief Version (WHOQOL BREF) instrument. The QoL of cancer patients was shown in mean and standard deviation, and the correlation between respondent characteristics and QoL was analyzed with Spearman.Results: The results showed that the average QoL of the respondents in the physical health was 30.36 ± 7.72, the intermediate psychological was 25.88 ± 9.14, the average social relationship was 59.90 ± 13.04, and the mean environment was 56.7 ± 10.93.Conclusions: Respondents’ low QoL during the COVID-19 pandemic for all domains. This study implies the importance of paying attention to every domain of the QoL of cancer patients, especially during the COVID-19 pandemic.

Copyrights © 2023






Journal Info

Abbrev

ijoc

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health

Description

Indonesian Journal of Cancer is a peer-reviewed and open-access journal. This journal is published quarterly (in March, June, September, and December) by Dharmais Cancer Hospital - National Cancer Center. Submissions are reviewed under a broad scope of topics relevant to experimental and clinical ...